Takeda joins consortium that accelerates R&D for malaria, TB vaccines

On Monday, Takeda announced its participation in WIPO Re:Search, a consortium to accelerate research and development of new drugs, vaccines and diagnostics for malaria and tuberculosis. "Takeda's participation in the consortium demonstrates our commitment to supporting better access to medicines for people around the world, including those in emerging markets and developing counties," said Isabel Torres, Takeda's director, access to medicines, in a statement. WIPO Re:Search was established in 2011 by the World Intellectual Property Organization and BIO ventures for Global Health. Release